CD274 and cancer: The enrichment of metabolic disease-related pathways, cancer-related pathways (e.g., PD-L1/PD-1 checkpoint pathway), and inflammatory bowel disease pathways suggested that BIS may share molecular-level associations with systemic inflammation and immune dysregulation.